Doctor Gisselle Gallego

Journal Articles

• Dew, A., Veitch, C., Lincoln, M., Brentnall, J., Bulkeley, K., Gallego, G., Bundy, A. and Griffiths, S. (2012), 'The need for new models for delivery of therapy intervention to people with a disability in rural and remote areas of Australia', Journal of Intellectual and Developmental Disability, 4.
• Veitch, C., Dew, A., Bulkeley, K., Lincoln, M., Bundy, A., Gallego, G. and Griffiths, S. (2012), 'Issues affecting therapist workforce and service delivery in the disability sector in rural and remote New South Wales, Australia : perspectives of policy-makers, managers and senior therapists', Rural and Remote Health, 12.
• Veitch, C., Lincoln, M., Bundy, A., Gallego, G., Dew, A., Bulkeley, K., Brentnall, J. and Griffiths, S. (2012), 'Integrating evidence into policy and sustainable disability services delivery in western New South Wales, Australia : the 'wobbly hub and doublespokes' project', BMC Health Services Research, 8.
• Gallego, G., Bridges, J., Flynn, T., Blauvelt, B. and Niessen, L. (2012), 'Using best-worst scaling in horizon scanning for hepatocellular carcinoma technologies', International Journal of Technology Assessment in Health Care, 8.
• Haas, M., Hall, J., Viney, R. and Gallego, G. (2012), 'Breaking up is hard to do : why disinvestment in medical technology is harder than investment', Australian Health Review, 5.
• Haywood, P., Raad, J., Gool, K., Haas, M., Gallego, G., Pearson, S., Faedo, M. and Ward, R. (2012), 'Chemotherapy administration : modelling the costs of alternative protocols', PharmacoEconomics, 14.
• Bridges, J., Joy, S., Gallego, G., Blauvelt, B., Geschwind, J. and Pawlik, T. (2012), 'Priorities for hepatocellular carcinoma (HCC) control : a comparison of policy needs in five European countries', Journal of Comparative Policy Analysis, 17.
• Gallego, G. (2012), 'Prioritizing strategies for comprehensive liver cancer control in Asia : a conjoint analysis', BMC Health Services Research, 12.
• Gallego, G. (2011), 'Hospital Drug and Therapeutics Committees in Australia: is there a role for economic evaluation at the institutional level?', International Journal of Clinical Pharmacy, 3.
• Gallego, G., Casey, R., Norman, R. and Goodall, S. (2011), 'Introduction and uptake of new medical technologies in the Australian health care system: A qualitative study', Health Policy, 7.
• Bridges, J., Gallego, G. and Blauvelt, B. (2011), 'Controlling liver cancer internationally: A qualitative study of clinicians' perceptions of current public policy needs', Health Research Policy and Systems, .
• Gallego, G., Taylor, S. and Brien, J. (2011), 'Setting priorities for high-cost medications in public hospitals in Australia: should the public be involved?', Australian Health Review, 6.
• Bridges, J., Joy, S., Gallego, G., Kudo, M., Ye, S., Han, K., Cheng, A. and Blauvelt, B. (2011), 'Needs for hepatocellular carcinoma (HCC) control policy in the Asia-Pacific region', Asian Pacific Journal of Cancer Prevention, 7.
• Gallego, G. and Harris, A. (2010), 'Evaluation in a disconnected healthcare system: problems and suggested solutions from the Australian HTA review', Expert Review of Pharmacoeconomics & Outcomes Research, 3.
• de Radd, J., van Gool, K., Haywood, P., Faedo, M., Gallego, G., Pearson, S. and Ward, R. (2010), 'Nursing takes time: workload associated with administering cancer protocols', Clinical Journal of Oncology Nursing, 7.
• Gallego, G., Goodall, S. and Eastman, C. (2010), 'Iodine deficiency in Australia: is iodine supplementation for pregnant and lactating women warranted?', Medical Journal of Australia, 3.
• Gallego, G., Taylor, S. and Brien, J. (2009), 'Funding and access to high cost medicines in public hospitals in Australia: Decision-makers' perspectives', Health Policy, 8.
• Gallego, G., van Gool, K. and Kelleher, D. (2009), 'Resource allocation and health technology assessment in Australia: Views from the local level', International Journal of Technology Assessment in Health Care, 7.
• Gallego, G., Fowler, S. and van Gool, K. (2008), 'Decision makers' perceptions of health technology decision making and priority setting at the institutional level', Australian Health Review, 8.
• van Gool, K., Gallego, G., Haas, M., Vinney, R., Hall, J. and Ward, R. (2007), 'Economic Evidence at the Local Level: Options for Making it More Useful', PharmacoEconomics, 8.
• Gallego, G., Taylor, S. and Brien, J. (2007), 'Priority setting for High Cost Medications (HCMs) in Public Hospitals in Australia: a case study', Health Policy, 9.
• Gallego, G., Taylor, S., McNeill, P. and Brien, J. (2007), 'Public views on priority setting for high cost medications in public hospitals in Australia', Health Expectations, 12.
• Gallego, G. and van Gool, K. (2007), 'Can we deny patients expensive drugs?', Australian Prescriber, 2.
• Gallego, G., Taylor, S. and Brien, J. (2007), 'Provision of pharmaceuticals in Australian hospitals: equity of access?', Pharmacy World and Science, 4.
• Gallego, G., Melocco, T., Taylor, S. and Brien, J. (2005), 'Access to High-Cost Drugs: Decision Makers Perspectives', Journal of Pharmacy Practice and Research, 3.
• Gallego, G., Melocco, T., Taylor, S. and Brien, J. (2004), 'Impact of High Cost Drugs for Individual Patient Use', Journal of Pharmacy Practice and Research, 4.